ArticleFrontiers in medicine2026
AI-driven saliency-guided retinal vessel segmentation framework for sustainable digital pathology.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Accurate segmentation of retinal blood vessels is essential for the early diagnosis of ophthalmic and systemic diseases such as diabetes, hypertension, and cardiovascular disorders. However, challenges such as low contrast, complex vessel geometry, and the presence of pathological artifacts often degrade segmentation performance, particularly for thin vessels and boundary regions. Methods: To address these challenges, this study proposes an AI-driven saliency-guided boundary refinement framework (SGB-Net). The model integrates a progressive boundary refinement (BR) module to enhance vessel edge representation and a feature-guided encoder-decoder network incorporating scale-adaptive (SA) and attention enhancement (AE) modules. The SA module captures multi-scale contextual features, while the AE module refines feature representations by emphasizing relevant structures and suppressing background noise. The proposed framework was evaluated on three publicly available datasets: DRIVE, STARE, and CHASE_DB1. Results: Experimental results demonstrate that the proposed method achieves superior segmentation performance, with Dice scores of 98.30%, 78.40%, and 84.60% on the DRIVE, STARE, and CHASE_DB1 datasets, respectively, and AUC values up to 0.9899. The model shows improved capability in preserving thin vessels, enhancing boundary continuity, and reducing false positives under complex imaging conditions compared to existing state-of-the-art methods. Discussion: The proposed SGB-Net effectively addresses key limitations in retinal vessel segmentation by combining boundary refinement with multi-scale and attention-based feature learning. Its robustness to noise and pathological variations makes it suitable for large-scale digital pathology applications and supports more reliable automated retinal analysis. Future work may focus on improving sensitivity and extending the framework to other medical imaging modalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.